G
Gordon H. Guyatt
Researcher at McMaster University
Publications - 1749
Citations - 262329
Gordon H. Guyatt is an academic researcher from McMaster University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 231, co-authored 1620 publications receiving 228631 citations. Previous affiliations of Gordon H. Guyatt include Memorial Sloan Kettering Cancer Center & Cayetano Heredia University.
Papers
More filters
Journal ArticleDOI
“Incomplete Resection” in Non–Small Cell Lung Cancer: Need for a New Definition
Yves Lacasse,Yves Lacasse,Heiner C. Bucher,Heiner C. Bucher,Eric Wong,Eric Wong,Lauren Griffith,Lauren Griffith,Stephen D. Walter,Stephen D. Walter,Robert J. Ginsberg,Robert J. Ginsberg,Gordon H. Guyatt,Gordon H. Guyatt +13 more
TL;DR: In patients with non-small cell lung cancer, surgical resection margin or highest nodal station sampled at thoracotomy that are involved by carcinoma do not predict recurrence, and the current definition of incomplete resection has limited prognostic significance.
Journal ArticleDOI
Trials Comparing Alternative Weaning Modes and Discontinuation Assessments
Maureen O. Meade,Gordon H. Guyatt,Tasnim Sinuff,Lauren Griffith,Lori Hand,Gemini Toprani,Deborah J. Cook +6 more
TL;DR: The results of these studies suggest the possibility that multiple daily T-piece weaning or pressure support may be superior to synchronized intermittent mandatory ventilation.
Journal ArticleDOI
Regular Versus As-Needed Short-Acting Inhaled β -Agonist Therapy for Chronic Obstructive Pulmonary Disease
Deborah J. Cook,Gordon H. Guyatt,Eric Wong,Roger S. Goldstein,Michel Bédard,Peggy Austin,Helen Ramsdale,Roman Jaeschke,Malcolm R. Sears +8 more
TL;DR: In patients with COPD, use of regular short-acting inhaled beta-agonists resulted in twice as much beta-agonist use without physiologic or clinical benefit as did use on an as-needed basis.
Journal ArticleDOI
Evaluation of new diagnostic technologies: Bronchoalveolar lavage and the diagnosis of ventilator-associated pneumonia
TL;DR: Criteria to aid intensive care workers in the assessment of diagnostic technologies is presented, using the example of bronchoalveolar lavage for the evaluation of ventilator-associated pneumonia.
Journal ArticleDOI
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Juan Pablo Diaz Martinez,Elena Kum,Anila Qasim,Dena Zeraatkar,Ariel Izcovich,Sophia O Mangala,Long Ge,Mi Ah Han,Thomas Agoritsas,Donald M. Arnold,Camila Ávila,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Farid Foroutan,Maryam Ghadimi,Assem M. Khamis,Francois Lamontagne,Mark Loeb,Anna Miroshnychenko,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,Gabriel Rada,Bram Rochwerg,Charlotte Switzer,Per Olav Vandvik,Robin W.M. Vernooij,Ying Wang,Liang Yao,Gordon H. Guyatt,Romina Brignardello-Petersen +36 more
TL;DR: In this paper, the authors evaluated the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19), with pairwise meta-analysis for outcomes with insufficient data.